Kallio JP - Search Results

1

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma.

Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Luukkaala T, Tammela TL, Martikainen PM. Kallio JP, et al. Br J Cancer. 2003 Oct 6;89(7):1266-9. doi: 10.1038/sj.bjc.6601241. Br J Cancer. 2003. PMID: 14520458 Free PMC article.

2

Renal cell carcinoma MIB-1, Bax and Bcl-2 expression and prognosis.

Kallio JP, Hirvikoski P, Helin H, Luukkaala T, Tammela TL, Kellokumpu-Lehtinen P, Martikainen PM. Kallio JP, et al. J Urol. 2004 Dec;172(6 Pt 1):2158-61. doi: 10.1097/01.ju.0000144334.97639.bf. J Urol. 2004. PMID: 15538222

3

Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer.

Kallio J, Hämäläinen M, Luukkaala T, Moilanen E, Tammela TL, Kellokumpu-Lehtinen PL. Kallio J, et al. Urol Oncol. 2017 Sep;35(9):544.e25-544.e31. doi: 10.1016/j.urolonc.2017.05.005. Epub 2017 May 29. Urol Oncol. 2017. PMID: 28572026

4

Soluble immunological parameters and early prognosis of renal cell cancer patients.

Kallio JP, Tammela TL, Marttinen AT, Kellokumpu-Lehtinen PL. Kallio JP, et al. J Exp Clin Cancer Res. 2001 Dec;20(4):523-8. J Exp Clin Cancer Res. 2001. PMID: 11876546

5

Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.

Kallio JP, Mahlamäki EH, Helin H, Karhu R, Kellokumpu-Lehtinen P, Tammela TL. Kallio JP, et al. Scand J Urol Nephrol. 2004;38(3):225-30. doi: 10.1080/00365590310025399. Scand J Urol Nephrol. 2004. PMID: 15204376

6

Antioxidant enzymes in renal cell carcinoma.

Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula LV. Soini Y, et al. Among authors: kallio jp. Histol Histopathol. 2006 Feb;21(2):157-65. doi: 10.14670/HH-21.157. Histol Histopathol. 2006. PMID: 16329040

7

Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.

Soini Y, Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Kang SW, Tammela TL, Peltoniemi M, Martikainen PM, Kinnula VL. Soini Y, et al. Among authors: kallio jp. APMIS. 2006 May;114(5):329-37. doi: 10.1111/j.1600-0463.2006.apm_315.x. APMIS. 2006. PMID: 16725008

8

Genetic variation in platelet integrin alphabeta (GPIIb/IIIa) and the metastatic potential of renal cell carcinoma.

Kallio JP, Mikkelsson J, Tammela TL, Karhunen PJ, Kellokumpu-Lehtinen P. Kallio JP, et al. BJU Int. 2006 Jul;98(1):201-4. doi: 10.1111/j.1464-410X.2006.06196.x. BJU Int. 2006. PMID: 16831169

9

High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.

Väänänen T, Kallio J, Vuolteenaho K, Ojala A, Luukkaala T, Hämäläinen M, Tammela T, Kellokumpu-Lehtinen PL, Moilanen E. Väänänen T, et al. Scand J Urol. 2017 Oct;51(5):367-372. doi: 10.1080/21681805.2017.1327885. Epub 2017 Jun 23. Scand J Urol. 2017. PMID: 28644702

10

The dilemma of suspicious urine cytology in patients being followed for bladder cancer.

Raitanen MP, Aine R, Kylmälä T, Kallio J, Liukkonen T, Tammela T; Finnbladder Group. Raitanen MP, et al. Ann Chir Gynaecol. 2001;90(4):256-9. Ann Chir Gynaecol. 2001. PMID: 11820413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters